Abstract
Our aim is to investigate a common role of the complement system in the pathogenesis of retinal disease, by assessing the expression profile of complement component 3 (C3) in three mechanistically distinct models of retinal degeneration: light-damage, hyperoxia and the degenerative P23H-3 rodent strain. In the light damage model, young adult albino Sprague Dawley (SD) rats were exposed to 1,000 lx for a period of up to 24 h, where at specific time points during and after exposure, animals were euthanized and retinas extracted for analysis. In the hyperoxia model, adult C57 mice were subjected to 75% oxygen for up to 14 days, then euthanized and retinas dissected for analysis. In the genetic model, SD and P23H-3 animals were born and reared until postnatal day 50–130, then euthanized and retinas extracted. For all three models, C3 mRNA expression levels were determined by quantitative PCR (qPCR), while photoreceptor death was quantified using the TUNEL technique. Up-regulation of C3 expression was evident in retinal tissue from all experimental models assessed. C3 expression in light damage showed a marked upregulation after 24 h of exposure, which continued into the post-exposure period. Modest increases in C3 were evident during early hyperoxia, which progressed to a substantial upregulation after 14 days. C3 expression in P23H retinas was consistently higher than those of non-degenerative SD retinas. Upregulation of C3 in all models was associated with substantial increases photoreceptor apoptosis. While the degenerative stimuli in these models differ, the increased expression of C3 in conjunction with increasing photoreceptor death provides evidence for a common pathway in retinal degeneration involving the activation of complement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Anderson DH, Radeke MJ, Gallo NB et al (2010) The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited. Prog Retin Eye Res 29:95–112
Despriet DD, van Duijn CM, Oostra BA, et al (2009) Complement component C3 and risk of age-related macular degeneration. Ophthalmology 116:474–480 e472
Figueroa E, Gordon LE, Feldhoff PW et al (2005) The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett 380:48–53
Gasque P (2004) Complement: a unique innate immune sensor for danger signals. Mol Immunol 41:1089–1098
Jakobsdottir J, Conley YP, Weeks DE et al (2008) C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One 3:e2199.
Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389
Rohrer B, Guo Y, Kunchithapautham K et al (2007) Eliminating complement Factor D reduces photoreceptor susceptibility to light-induced damage. Invest Ophthalmol Vis Sci 48:5282–5289
Trouw LA, Blom AM, Gasque P (2008) Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol 45:1199–1207
Walport MJ (2001) Complement: Second of two parts. N Eng J Med 344:1140–1144
Yang S, Nakamura T, Hua Y et al (2006) The role of complement C3 in intracerebral hemorrhage-induced brain injury. J Cereb Blood Flow Metab 26:1490–1495
Yates JR, Sepp T, Matharu BK et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357:553–561
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this paper
Cite this paper
Rutar, M., Natoli, R., Provis, J., Valter, K. (2012). Complement Activation in Retinal Degeneration. In: LaVail, M., Ash, J., Anderson, R., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 723. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0631-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0631-0_5
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0630-3
Online ISBN: 978-1-4614-0631-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)